SCHEMBL18220892

SCHEMBL18220892

CCCc1c(CN(C)CC(C)(C)O)sc(NC(=O)Nc2ccc(Cl)cc2)c1C(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 12/20 0.44
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.40
CYP3A4 P08684 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
XBP1 P17861 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
GAA P10253 1/20 0.37
MAPK14 Q16539 1/20 0.37
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18220878 0.83 KCNH2 (0.53) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL17022059 0.83 KCNH2 (0.47) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL18220901 0.82 KCNH2 (0.45) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL17022056 0.81 P2RX7 (0.44) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL18220908 0.78 KCNH2 (0.43) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL17022068 0.77 KCNH2 (0.46) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL18220889 0.76 KCNH2 (0.43) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL18015404 0.76 MEN1 (0.55) KCNH2MEN1KMT2AALDH1A1HPGD
SCHEMBL17022062 0.69 RAB9A (0.39) KCNH2MEN1KMT2AALDH1A1MAPT
SCHEMBL18902237 0.68 MEN1 (0.48) KCNH2MEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160326186-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH FRED HUTCHINSON CANCER CENTER 2016-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160326186-A1 COMPOUNDS AND METHODS FOR PREVENTING, TREATING AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH BAX, CASP3, BCL2 KCNH2 2265/4885MEN1 4393/4885KMT2A 4772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.